Bromodomain and extraterminal (BET) protein inhibition of IgG/IgE production in murine B cells is counter‐balanced by a strong Th2 bias

OBJECTIVES: Inhibitors of bromodomain and extra terminal domain (BET) proteins are a new and growing class of anti‐cancer drugs, which decrease oncogene expression by targeting superenhancers. Antibody production is another physiological process relying on superenhancers, and it remains to be clarif...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Transl Immunology
Päätekijät: Dalloul, Zeinab, Best, Marie, Chenuet, Pauline, Dalloul, Iman, Le Noir, Sandrine, Togbé, Dieudonnée, Gador, Mylène, Ryffel, Bernhard, FJ Quesniaux, Valerie, El Makhour, Yolla, Boyer, François, Aldigier, Jean‐Claude, Cook‐Moreau, Jeanne, Fazilleau, Nicolas, Cogné, Michel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164936/
https://ncbi.nlm.nih.gov/pubmed/34136216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1280
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia